Ryman Healthcare has the potential to become one of the best “large cap equity stories” in New Zealand, according to Forsyth Barr analysts.
In a recent research note, the investment house said the company was “changing its stripes more than the market was giving its credit for”, referring to
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
